19.05.2011 • NewsGen-ProbeThermo FisherNovartis

Bidders Emerge For Gen-Probe, Phadia

Bidders emerged for allergy-testing company Phadia and diagnostic test-maker Gen-Probe, according to The Wall Street Journal.

Laboratory equipment company Thermo Fisher Scientific is a leading contender for privately owned Phadia, and is involved in the auction for Gen-Probe, the newspaper reported in its online edition.

Phadia could fetch as much as $3 billion in a sale, while Gen-Probe has a market capitalization of $3.8 billion.

Other bidders for Gen-Probe include Novartis, and Life Technologies Corp, the newspaper said.

Gen-Probe, Phadia, Thermo Fisher declined to comment. Life Technologies and Novartis, which has a partnership with Gen-Probe, could not be immediately reached for comment.

Last month, Gen-Probe hired Morgan Stanley to seek a buyer for the company, sources familiar with the situation said.

 

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.